HOWL
Price
$1.09
Change
+$0.02 (+1.85%)
Updated
May 22, 12:39 PM (EDT)
Capitalization
51.16M
77 days until earnings call
KYMR
Price
$30.34
Change
+$0.21 (+0.70%)
Updated
May 22, 12:42 PM (EDT)
Capitalization
2.05B
71 days until earnings call
Interact to see
Advertisement

HOWL vs KYMR

Header iconHOWL vs KYMR Comparison
Open Charts HOWL vs KYMRBanner chart's image
Werewolf Therapeutics
Price$1.09
Change+$0.02 (+1.85%)
Volume$100
Capitalization51.16M
Kymera Therapeutics
Price$30.34
Change+$0.21 (+0.70%)
Volume$500
Capitalization2.05B
HOWL vs KYMR Comparison Chart
Loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOWL vs. KYMR commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Buy and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (HOWL: $1.08 vs. KYMR: $30.13)
Brand notoriety: HOWL and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 250% vs. KYMR: 82%
Market capitalization -- HOWL: $51.16M vs. KYMR: $2.05B
HOWL [@Biotechnology] is valued at $51.16M. KYMR’s [@Biotechnology] market capitalization is $2.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, HOWL is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 6 TA indicator(s) are bullish while KYMR’s TA Score has 6 bullish TA indicator(s).

  • HOWL’s TA Score: 6 bullish, 3 bearish.
  • KYMR’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, HOWL is a better buy in the short-term than KYMR.

Price Growth

HOWL (@Biotechnology) experienced а +9.09% price change this week, while KYMR (@Biotechnology) price change was +1.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.02%. For the same industry, the average monthly price growth was +7.66%, and the average quarterly price growth was -1.31%.

Reported Earning Dates

HOWL is expected to report earnings on Aug 07, 2025.

KYMR is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Biotechnology (+5.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.05B) has a higher market cap than HOWL($51.2M). KYMR YTD gains are higher at: -25.106 vs. HOWL (-27.027). HOWL has higher annual earnings (EBITDA): -65.72M vs. KYMR (-232.67M). KYMR has more cash in the bank: 463M vs. HOWL (92M). HOWL has less debt than KYMR: HOWL (37M) vs KYMR (86.3M). KYMR has higher revenues than HOWL: KYMR (58.9M) vs HOWL (1.14M).
HOWLKYMRHOWL / KYMR
Capitalization51.2M2.05B3%
EBITDA-65.72M-232.67M28%
Gain YTD-27.027-25.106108%
P/E RatioN/AN/A-
Revenue1.14M58.9M2%
Total Cash92M463M20%
Total Debt37M86.3M43%
TECHNICAL ANALYSIS
Technical Analysis
HOWLKYMR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 7 days ago
82%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APWIX12.29N/A
N/A
AB Sustainable Thematic Bal Port I
JLPSX21.10N/A
N/A
JPMorgan US Large Cap Core Plus I
LBSCX32.82N/A
N/A
Columbia Dividend Income C
ABMIX22.61N/A
N/A
AMG River Road Mid Cap Value I
PABFX17.82N/A
N/A
PGIM Balanced Z

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
-5.26%
GBIO - HOWL
42%
Loosely correlated
-2.16%
KYMR - HOWL
41%
Loosely correlated
-4.17%
AURA - HOWL
40%
Loosely correlated
+0.51%
CLDX - HOWL
39%
Loosely correlated
-2.64%
IPSC - HOWL
38%
Loosely correlated
-3.40%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-4.17%
CCCC - KYMR
64%
Loosely correlated
-8.11%
RCKT - KYMR
58%
Loosely correlated
-3.80%
RVMD - KYMR
57%
Loosely correlated
-4.27%
IMNM - KYMR
56%
Loosely correlated
-7.48%
NRIX - KYMR
56%
Loosely correlated
-3.55%
More